Thu, November 4, 2021
Wed, November 3, 2021
Tue, November 2, 2021
Mon, November 1, 2021
Sun, October 31, 2021
Sat, October 30, 2021
Fri, October 29, 2021

Andrew Fein Maintained (VRTX) at Strong Buy and Held Target at $275 on, Nov 2nd, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-275-on-nov-2nd-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Andrew Fein of HC Wainwright & Co., Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy and Held Target at $275 on, Nov 2nd, 2021.

Andrew has made no other calls on VRTX in the last 4 months.



There are 6 other peers that have a rating on VRTX. Out of the 6 peers that are also analyzing VRTX, 1 agrees with Andrew's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $213 on, Thursday, September 9th, 2021


These are the ratings of the 5 analyists that currently disagree with Andrew


  • Brian Skorney of "Baird" Maintained at Buy and Held Target at $240 on, Tuesday, October 19th, 2021
  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $202 on, Tuesday, September 7th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $248 on, Friday, July 30th, 2021
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $323 on, Friday, July 30th, 2021
  • Geoffrey Porges of "SVB Leerink" Maintained at Sell with Increased Target to $175 on, Friday, July 30th, 2021

Publication Contributing Sources